February, 2025

article thumbnail

STAT+: Class action suit over UnitedHealth’s AI care denials nears key moment

STAT

A federal judge will soon decide whether a class action lawsuit against UnitedHealth Group and its algorithm-based care denials can move forward, which would potentially open the door for attorneys to sift through the company’s internal communications. The lawsuit, in U.S. District Court in Minnesota, alleges that UnitedHealth and its subsidiary NaviHealth relied on flawed algorithms to cut off essential rehabilitative care to sick and injured Medicare Advantage beneficiaries.

article thumbnail

Drugmakers prep for bird flu outbreak, despite continued low risk

PharmaVoice

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are coming through the pipes if it does.

Vaccines 217
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

LifeProNow

January 30, 2025: “The U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx reduces pain by targeting a pain-signaling pathway involving sodium channels in the peripheral nervous system, before pain signals reach the brain.

article thumbnail

November-December 2024

Safe Biologics

Michael Reilly in RealClearHealth: Don’t Let a “Lame Duck” Congress Gamble with Patient Health On December 20th, RealClearHealth published an op-ed by ASBM Executive Director Michael Reilly discussing concerns that the Biosimilar Red Tape Elimination Act would lower standards for biosimilar medications. The opinion highlights concerns that this bill might be included in the end of year continuing resolution bill, without properly considering the impacts on patients.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Pharma M&A and venture capital deals reach $33.7 billion in Jan 2025

Express Pharma

The healthcare industry reported 107 mergers and acquisitions (M&A) deals worth $29.2 billion in January 2025, according to data from GlobalData. This is higher than the last 12-month (January 2024 to December 2024) average of 99 deals worth $14 billion. Johnson & Johnson announced the acquisition of Intra-Cellular Therapies, a biopharmaceutical company, for a total equity value of approximately $14.6 billion.

article thumbnail

Vertex challenger Sionna prices $191M IPO

BioPharma Dive

The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or be used in new, multi-drug combinations.

110
110

More Trending

article thumbnail

Tariffs raise concern among generic drugmakers, and advocacy groups are seeking exemptions

PharmaVoice

While the 10% tariff on Chinese goods won’t have too much impact on branded drugs, generics are struggling to pivot.

147
147
article thumbnail

Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn

Pharmaceutical Technology

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the strong growth potential of Japans healthcare industry.

104
104
article thumbnail

Nitrofurantoin recall as extra tablet found in packs of UTI antibiotics

The Pharmacist

Two batches of nitrofurantoin 100mg prolonged-release capsules have been recalled after a small number of packs were found to contain an additional tablet of nitrofurantoin. Nitrofurantoin is used to treat Urinary Tract Infections (UTIs), and six 100mg modified release capsules can be supplied under the NHS England Pharmacy First Patient Group Direction (PGD) for uncomplicated […] The post Nitrofurantoin recall as extra tablet found in packs of UTI antibiotics appeared first on The Pharmac

article thumbnail

Aplagon secures EUR 7 million for APAC phase 2a trials

Pharma Times

Funding led by new investors FSG and EIC Fund

101
101
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Shares of psychedelics biotech nearly double on depression data

BioPharma Dive

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was fast and effective in a treatment-resistant depression trial.

114
114
article thumbnail

Here is how we know that vaccines do not cause autism

STAT

Vaccines do not cause autism. You’ve almost certainly read that before — probably hundreds of times. But many people do not believe it, perhaps because too often it is repeated without a real explanation of how we know that. So here is an attempt to offer that explanation.

Vaccines 364
article thumbnail

Bristol Myers gives first peek at closely watched launch of schizophrenia drug

PharmaVoice

Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the fourth quarter and around 1,000 prescriptions weekly by late January.

130
130
article thumbnail

Sanofi’s Sarclisa combo approved in China for multiple myeloma

Pharmaceutical Technology

Sanofi has received Chinas NMPA approval for the use of Sarclisa, combined with a standard-of-care regimen, for treating adults with NDMM.

104
104
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Seven million hours of pharmacy access lost in two years

The Pharmacist

Patients in England have lost around seven million hours of pharmacy access in the last two years, analysis from the National Pharmacy Association (NPA) has suggested. And around one in eight have seen their local pharmacy close for good, the NPA said. Inadequate funding could force pharmacies to reduce access by a further one million […] The post Seven million hours of pharmacy access lost in two years appeared first on The Pharmacist.

87
article thumbnail

BMS extends its cost-cutting drive by another $2bn

pharmaphorum

BMS is extending its bid to cut costs by $1.5bn before the end of this year, backed by 2,200 job cuts, adding a target of another $2bn by end-2027.

93
article thumbnail

Pfizer drug acquired in $11B buyout confirms benefit in colon cancer

BioPharma Dive

The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval — boosting an oncology portfolio Pfizer is looking to for revenue growth.

111
111
article thumbnail

Opinion: NIH must address the twin crises of long Covid and ME/CFS — together

STAT

The National Institutes of Health is at a crossroads with the RECOVER Initiative, its flagship program to address long Covid. Designed to provide answers and treatments for the millions suffering from long-term effects of SARS-CoV-2 infection, the initiative has already received significant criticism for failing to prioritize the needs of patients and advance meaningful clinical trials.

363
363
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

With uncertainty roiling Big Pharma, execs are placing lower-risk bets

PharmaVoice

The market has been no less demanding for pharma giants as 2025 begins, but last year’s strategies are paying off.

130
130
article thumbnail

Thermo Fisher continues viral vector withdrawal; lays off 300 employees

Pharmaceutical Technology

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

100
100
article thumbnail

CHMP recommends SC Rybrevant for EGFR-mutated NSCLC patients

Pharma Times

Positive opinion issued for marketing authorisation extension

95
article thumbnail

Novo rises on Wegovy sales leap, but warns of a slowdown

pharmaphorum

Novo Nordisk is expecting greater competition and pricing pressure in the obesity and diabetes sectors this year.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Is 2025 the Chinese Year of BioPharma?

BioPharma Dive

China is now a dealmaking hot spot for firms seeking next-generation innovation. What will 2025 hold?

102
102
article thumbnail

Remembering a remarkable Duchenne champion

STAT

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox.

306
306
article thumbnail

What should pharma make of the FDA going dark on DEI?

PharmaVoice

After a series of potent executive orders last week, the FDA removed draft guidance on diversity in clinical trials.

130
130
article thumbnail

99 per cent of life sciences leaders see AI boosting revenue management in 2025: Report

Express Pharma

Model Ns 2025 State of Revenue Report reveals shifts toward use of generative AI and automation to bolster pharmaceutical, medtech, and high-tech revenue programs Model N published its seventh annual State of Revenue Report, highlighting how executives in these industries are transforming their revenue operations. The report reveals that while 87 per cent of industry leaders are shifting toward automated revenue management operations, nearly 60 per cent still rely on multiple solutions.

92
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Novartis secures MHRA authorisation for ribociclib

Pharma Times

Breast cancer therapy offers hope for patients at risk of recurrence

88
article thumbnail

GH Research leaps on psychedelic data in depression

pharmaphorum

After setbacks with psychedelics, phase 2b data with GH Research's GH001 for treatment-resistant depression could lift confidence in the category

94
article thumbnail

Drugmakers prep for bird flu outbreak, despite continued low risk

BioPharma Dive

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

article thumbnail

STAT+: The CRISPR companies are not OK

STAT

A strange thing happened weeks before the Food and Drug Administration approved the first treatment made with CRISPR gene editing , an all-but cure for certain patients with sickle cell disease. CRISPR Therapeutics, the biotech that co-developed the therapy, laid off about 50 employees. “We were dumbfounded,” said a scientist who was let go.

328
328
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.